Article
A New Multicolor Bioluminescence Imaging Platform to Investigate NF-κB Activity and Apoptosis in Human Breast Cancer Cells
17 Jan 2014
Abstract excerpt
BACKGROUND: Evaluation of novel drugs for clinical development depends on screening technologies and informative preclinical models. Here we developed a multicolor bioluminescent imaging platform to simultaneously investigate transcription factor NF-κB signaling and apoptosis. METHODS: The human breast cancer cell line (MDA-MB-231) was genetically modified to express green, red and blue light emitting luciferases...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
